Plerixafor 24 mg/1.2mL

Plerixafor 24 mg/1.2mL is a subcutaneous injection solution used to mobilize hematopoietic stem cells. This medication is often used in preparation for stem cell transplantation procedures. It is manufactured by Teva Pharmaceuticals, Inc. in the USA.

Plerixafor is primarily used to mobilize hematopoietic stem cells from the bone marrow into the bloodstream. This process is crucial for patients undergoing stem cell transplantation, particularly those who have not responded adequately to other mobilization treatments. The medication works by blocking a receptor that keeps stem cells in the bone marrow, allowing them to move into the blood where they can be collected. Plerixafor is often used in combination with other drugs to enhance the effectiveness of the mobilization process.

Common effects of Plerixafor may include injection site reactions such as redness, swelling, or pain. Some individuals might experience nausea, diarrhea, or headaches. These effects are generally mild and temporary. It is important to consult with a healthcare provider if any of these effects persist or worsen.

Plerixafor should be handled with care, ensuring proper storage and administration as directed by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before using this medication. Pregnant or breastfeeding women should discuss the potential risks and benefits with their healthcare provider.

Plerixafor may interact with other medications, particularly those that affect the immune system or bone marrow. It is important to inform your healthcare provider about all medications you are currently taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also interact with Plerixafor, so it is advisable to follow your healthcare provider's guidance on diet and lifestyle during treatment.